nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.196	0.409	CbGbCtD
Ketamine—ABCB1—Lisinopril—dilated cardiomyopathy	0.15	0.314	CbGbCtD
Ketamine—ABCB1—Spironolactone—dilated cardiomyopathy	0.132	0.277	CbGbCtD
Ketamine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00445	0.496	CbGeAlD
Ketamine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.0024	0.267	CbGeAlD
Ketamine—Bladder pain—Furosemide—dilated cardiomyopathy	0.000881	0.0632	CcSEcCtD
Ketamine—GRIN2A—heart—dilated cardiomyopathy	0.000757	0.0844	CbGeAlD
Ketamine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000714	0.0512	CcSEcCtD
Ketamine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00071	0.0509	CcSEcCtD
Ketamine—Cystitis—Lisinopril—dilated cardiomyopathy	0.000706	0.0506	CcSEcCtD
Ketamine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000661	0.0474	CcSEcCtD
Ketamine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000639	0.0458	CcSEcCtD
Ketamine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000531	0.0381	CcSEcCtD
Ketamine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000437	0.0314	CcSEcCtD
Ketamine—Erythema—Furosemide—dilated cardiomyopathy	0.000426	0.0306	CcSEcCtD
Ketamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000406	0.0291	CcSEcCtD
Ketamine—Rash—Spironolactone—dilated cardiomyopathy	0.000403	0.0289	CcSEcCtD
Ketamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000403	0.0289	CcSEcCtD
Ketamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000401	0.0288	CcSEcCtD
Ketamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00038	0.0272	CcSEcCtD
Ketamine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000374	0.0268	CcSEcCtD
Ketamine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000348	0.0249	CcSEcCtD
Ketamine—Shock—Furosemide—dilated cardiomyopathy	0.000342	0.0245	CcSEcCtD
Ketamine—Anorexia—Furosemide—dilated cardiomyopathy	0.000331	0.0238	CcSEcCtD
Ketamine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000328	0.0235	CcSEcCtD
Ketamine—Hypotension—Furosemide—dilated cardiomyopathy	0.000325	0.0233	CcSEcCtD
Ketamine—PTGS1—myocardium—dilated cardiomyopathy	0.000322	0.0358	CbGeAlD
Ketamine—Erythema—Lisinopril—dilated cardiomyopathy	0.00032	0.0229	CcSEcCtD
Ketamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000302	0.0217	CcSEcCtD
Ketamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000301	0.0216	CcSEcCtD
Ketamine—Pain—Furosemide—dilated cardiomyopathy	0.000297	0.0213	CcSEcCtD
Ketamine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000261	0.0187	CcSEcCtD
Ketamine—Shock—Lisinopril—dilated cardiomyopathy	0.000257	0.0184	CcSEcCtD
Ketamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000249	0.0178	CcSEcCtD
Ketamine—CYP2B6—heart—dilated cardiomyopathy	0.000248	0.0277	CbGeAlD
Ketamine—CYP2C9—heart—dilated cardiomyopathy	0.000246	0.0274	CbGeAlD
Ketamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000244	0.0175	CcSEcCtD
Ketamine—TACR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00024	0.000481	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000239	0.000479	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000233	0.000467	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000232	0.000466	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000231	0.000464	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000229	0.00046	CbGpPWpGaD
Ketamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000227	0.0163	CcSEcCtD
Ketamine—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000226	0.000452	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000225	0.000452	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000224	0.00045	CbGpPWpGaD
Ketamine—PTGS1—heart—dilated cardiomyopathy	0.000224	0.025	CbGeAlD
Ketamine—Pain—Lisinopril—dilated cardiomyopathy	0.000223	0.016	CcSEcCtD
Ketamine—Vomiting—Furosemide—dilated cardiomyopathy	0.000221	0.0159	CcSEcCtD
Ketamine—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000221	0.000443	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CD36—dilated cardiomyopathy	0.00022	0.00044	CbGpPWpGaD
Ketamine—Rash—Furosemide—dilated cardiomyopathy	0.000219	0.0157	CcSEcCtD
Ketamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000219	0.0157	CcSEcCtD
Ketamine—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000218	0.000438	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000218	0.000436	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000217	0.000436	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000217	0.000436	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000217	0.000435	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000217	0.000435	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—RAF1—dilated cardiomyopathy	0.000217	0.000435	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CD36—dilated cardiomyopathy	0.000214	0.000429	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—RAF1—dilated cardiomyopathy	0.000211	0.000424	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000209	0.00042	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—RAC1—dilated cardiomyopathy	0.000207	0.000415	CbGpPWpGaD
Ketamine—Nausea—Furosemide—dilated cardiomyopathy	0.000207	0.0148	CcSEcCtD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000206	0.000412	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000204	0.000409	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—RAC1—dilated cardiomyopathy	0.000202	0.000404	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000199	0.000399	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000198	0.000398	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000196	0.000393	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—RAF1—dilated cardiomyopathy	0.000192	0.000386	CbGpPWpGaD
Ketamine—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000192	0.0214	CbGeAlD
Ketamine—GRIN2B—Axon guidance—RAF1—dilated cardiomyopathy	0.000187	0.000376	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000187	0.000374	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000186	0.000373	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000186	0.000372	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000185	0.000371	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000185	0.000371	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000184	0.000369	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000184	0.000369	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000184	0.000369	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00018	0.00036	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000178	0.000356	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000177	0.000355	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000177	0.000355	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000176	0.000353	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000176	0.000353	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000176	0.000353	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000172	0.000346	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000172	0.000345	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000171	0.000343	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000169	0.000339	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000168	0.000337	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000168	0.000337	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000168	0.000336	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000167	0.000334	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000167	0.000334	CbGpPWpGaD
Ketamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000166	0.0119	CcSEcCtD
Ketamine—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000166	0.000332	CbGpPWpGaD
Ketamine—Rash—Lisinopril—dilated cardiomyopathy	0.000164	0.0118	CcSEcCtD
Ketamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000164	0.0118	CcSEcCtD
Ketamine—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000164	0.00033	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000164	0.000329	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000163	0.000327	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000163	0.000327	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000162	0.000325	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000162	0.000325	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000161	0.000324	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000159	0.000318	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000156	0.000313	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000155	0.000312	CbGpPWpGaD
Ketamine—Nausea—Lisinopril—dilated cardiomyopathy	0.000155	0.0111	CcSEcCtD
Ketamine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000152	0.000304	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000151	0.000303	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000151	0.000302	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000149	0.0003	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000147	0.000295	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000147	0.000295	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000146	0.000293	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000142	0.000285	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000141	0.000284	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000141	0.000282	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—RAF1—dilated cardiomyopathy	0.000137	0.000275	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000137	0.000275	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000137	0.000275	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000137	0.000275	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000135	0.000272	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000135	0.000271	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000134	0.000269	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—RAF1—dilated cardiomyopathy	0.000134	0.000268	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000133	0.000267	CbGpPWpGaD
Ketamine—ABCB1—heart—dilated cardiomyopathy	0.000133	0.0148	CbGeAlD
Ketamine—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000133	0.000266	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—EGFR—dilated cardiomyopathy	0.000132	0.000264	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000131	0.000263	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000131	0.000262	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000129	0.000259	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000129	0.000258	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—EGFR—dilated cardiomyopathy	0.000128	0.000258	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000128	0.000257	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000127	0.000256	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000127	0.000255	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000127	0.000254	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000126	0.000252	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000125	0.00025	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000124	0.00025	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000124	0.00025	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000123	0.000248	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000123	0.000246	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000119	0.000239	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000118	0.000237	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000116	0.000232	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000113	0.000227	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000112	0.000225	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000112	0.000225	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000112	0.000224	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00011	0.000222	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.00011	0.000221	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00011	0.000221	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000108	0.000216	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000107	0.000216	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000105	0.000211	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000105	0.00021	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000104	0.000208	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000104	0.000208	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000104	0.000208	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000103	0.000207	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000102	0.000204	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.0001	0.000201	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.0001	0.000201	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.98e-05	0.0002	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	9.95e-05	0.0002	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.92e-05	0.000199	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.92e-05	0.000199	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.89e-05	0.000198	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.8e-05	0.000197	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	9.68e-05	0.000194	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.66e-05	0.000194	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.57e-05	0.000192	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGT—dilated cardiomyopathy	9.53e-05	0.000191	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.51e-05	0.000191	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.43e-05	0.000189	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.43e-05	0.000189	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EGFR—dilated cardiomyopathy	9.41e-05	0.000189	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	9.37e-05	0.000188	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.35e-05	0.000188	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.23e-05	0.000185	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.19e-05	0.000184	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EGFR—dilated cardiomyopathy	9.17e-05	0.000184	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	9.09e-05	0.000182	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.08e-05	0.000182	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TNF—dilated cardiomyopathy	8.96e-05	0.00018	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.93e-05	0.000179	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.91e-05	0.000179	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.78e-05	0.000176	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	8.77e-05	0.000176	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	8.76e-05	0.000176	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—dilated cardiomyopathy	8.73e-05	0.000175	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.7e-05	0.000175	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.7e-05	0.000175	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.49e-05	0.00017	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.34e-05	0.000167	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	8.33e-05	0.000167	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.28e-05	0.000166	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.09e-05	0.000162	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.99e-05	0.00016	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	7.97e-05	0.00016	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.83e-05	0.000157	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.76e-05	0.000156	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.68e-05	0.000154	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.63e-05	0.000153	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.58e-05	0.000152	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.51e-05	0.000151	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.42e-05	0.000149	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.35e-05	0.000148	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.35e-05	0.000148	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.26e-05	0.000146	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.24e-05	0.000145	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.05e-05	0.000141	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.88e-05	0.000138	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.84e-05	0.000137	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	6.79e-05	0.000136	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.74e-05	0.000135	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.69e-05	0.000134	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.62e-05	0.000133	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.62e-05	0.000133	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.56e-05	0.000132	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.39e-05	0.000128	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.39e-05	0.000128	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.35e-05	0.000127	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.31e-05	0.000127	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.28e-05	0.000126	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.22e-05	0.000125	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.88e-05	0.000118	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.77e-05	0.000116	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.75e-05	0.000115	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.71e-05	0.000115	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.66e-05	0.000113	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.62e-05	0.000113	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.62e-05	0.000113	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.57e-05	0.000112	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.57e-05	0.000112	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.53e-05	0.000111	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.45e-05	0.000109	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.44e-05	0.000109	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	5.37e-05	0.000108	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.37e-05	0.000108	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.34e-05	0.000107	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.34e-05	0.000107	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.2e-05	0.000104	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.18e-05	0.000104	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	5.11e-05	0.000102	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.02e-05	0.000101	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.93e-05	9.88e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	4.71e-05	9.44e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.68e-05	9.39e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.68e-05	9.38e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.61e-05	9.25e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.54e-05	9.1e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	4.52e-05	9.07e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CD36—dilated cardiomyopathy	4.41e-05	8.84e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.33e-05	8.68e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.29e-05	8.6e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.17e-05	8.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.07e-05	8.15e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	3.98e-05	7.98e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AGT—dilated cardiomyopathy	3.97e-05	7.96e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.79e-05	7.61e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.73e-05	7.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.54e-05	7.11e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.49e-05	7.01e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	3.45e-05	6.92e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	3.36e-05	6.74e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.31e-05	6.64e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.27e-05	6.55e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.21e-05	6.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.16e-05	6.33e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	3.03e-05	6.07e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	3.02e-05	6.05e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	2.92e-05	5.86e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	2.85e-05	5.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.76e-05	5.54e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	2.56e-05	5.14e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.56e-05	5.13e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.55e-05	5.11e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.48e-05	4.97e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.43e-05	4.87e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.38e-05	4.77e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.32e-05	4.65e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.24e-05	4.49e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.23e-05	4.48e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.09e-05	4.2e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.09e-05	4.18e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.89e-05	3.8e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.57e-05	3.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.53e-05	3.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.44e-05	2.88e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.38e-05	2.76e-05	CbGpPWpGaD
